COMMUNIQUÉS West-GlobeNewswire

-
Kiniksa Pharmaceuticals Reports Second Quarter 2025 Financial Results and Recent Portfolio Execution
29/07/2025 -
Radiopharm Theranostics reports Fiscal Year 2025 Financial Results and Business Update
29/07/2025 -
BriaCell’s Subsidiary, BriaPro, Files Patent Application for Immuno-Oncology Platform with Novel Multitargeting Agents
29/07/2025 -
Cognition Therapeutics Presents Data at AAIC Highlighting Broad Neurological Impact of Zervimesine (CT1812) in Dementia with Lewy Bodies and Alzheimer’s Disease
29/07/2025 -
Maziar Mike Doustdar appointed as president and chief executive officer of Novo Nordisk
29/07/2025 -
Izotropic’s IzoView Breast CT Device Stands Distinct vs Existing Breast Imaging Technologies
29/07/2025 -
Praxis Precision Medicines to Host Conference Call to Announce Topline Results from the RADIANT Trial and Provide Second Quarter 2025 Financial Results
29/07/2025 -
Cingulate Receives $4.3M Waiver from FDA Ahead of Imminent Filing for Marketing Approval of Lead ADHD Asset CTx-1301
29/07/2025 -
Calidi Biotherapeutics Receives FDA Fast Track Designation for CLD-201 (SuperNova), a First-In-Class Stem-Cell Loaded Viral Therapy for the Treatment of Patients with Soft Tissue Sarcoma
29/07/2025 -
ProMIS Neurosciences to Showcase Protein-Misfolding Drug Discovery Platform & PRECISE-AD Trial Design at the 2025 Alzheimer’s Association International Conference
29/07/2025 -
Exagen Inc. Reports Strong Q2 2025 Results
29/07/2025 -
Vivex Biologics, Inc. Completes Subject Enrollment for its ASCEND Trial Evaluating VIA Disc NP™ for Symptomatic Disc Degeneration
29/07/2025 -
UroGen Pharma to Report Second Quarter 2025 Financial Results on Thursday, August 7th, 2025
29/07/2025 -
Immutep to Present Pivotal TACTI-004 Trial in Progress Poster at the 2025 World Conference on Lung Cancer
29/07/2025 -
Daré Bioscience and Rosy Wellness Launch First Phase of Patient-Focused Campaign to Support DARE to PLAY™ Sildenafil Cream
29/07/2025 -
ProPhase Labs Announces Special Meeting of Shareholders and Filing of Preliminary Proxy Statement
29/07/2025 -
Therini Bio Announces First Patient Dosed in Phase 1b Trial of THN391 in Alzheimer’s Disease
29/07/2025 -
Branded Legacy, Inc. Signs Letter of Intent to Acquire Bio-Legacy Evaluative Group, Advancing Innovations in Intranasal Drug Delivery
29/07/2025 -
Cedar Gate Data Finds Nearly 60% of New Mothers Miss Essential Postpartum Follow-Up Care
29/07/2025
Pages